Farhan Jalees Ahmad
Jamia Hamdard, KNMIPER, University of Delhi, chemfar organics pvt ltd
About
Farhan Jalees Ahmad, PhD, is currently a Professor, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India is an internationally known researcher in the area of Pharmaceutical Sciences. Having obtained his degree in M.Pharma and Ph.D (Pharmaceutics) from Jamia Hamdard, he continues to teach and leads a very productive research group which has been funded extensively by National and international funding agencies.
The focus of his group has been in the area of Nanomedicine and many of his nano products have been approved by the DCGI and successfully transferred to the Defense Services for use in the armed forces. Nano DPI with a lung deposition of >60% was clinically proved in patients of COPD. His work on iron oxide magnetic nanoparticles showed advantages of combined paclitaxel and curcumin in terms of reducing toxicities and improving therapeutic effects in the treatment of solid tumors.
He has published more than 450 publications, 12 Book chapters, 16 books and has two US patent, three PCTs and 24 Indian patents. With a total citation of 13059, H Index of 52 and i-10 index of 288, Professor Ahmad's work has been clearly well received by the scientific community. He has supervised -35 M. Pharma students and -43 PhD scholars. Besides this, he continues to offer consultancy to small pharmaceutical setups.
He has earned many accolades including Young Scientist Fast Track from DST, Scientist of the Year-2005 from NESA, UGC Research Award 2011, Bharat Jyoti Award 2011, Pharma Ratan 2017, ABAP Senior Scientist Award 2017 and also prizes in scientific poster session in National Pharmacy Symposium.
He played a pivotal role in developing and maintaining the state-of-the-art Nanomedicine Lab and Central Instrumentation Facility at Faculty of Pharmacy. He is an active member of bodies like IPA, APTI, NESA, MAAS, IPGA, IHPA, CRS and ICA, and also holds their life memberships. He has served IPA, Delhi Branch in the capacity of Member Executive Committee, Honorary Secretary and as President for two terms. He has served also as General Secretary for SPDS(Society for Pharmaceutical Dissolution Science), North chapter.
Employment
-
Jamia Hamdard Professor2009 - Present
-
Jamia Hamdard Associate Professor2003 - 2009
-
Jamia Hamdard lecturer1998 - 2003
-
KNMIPER Lecturer1997 - 1998
-
chemfar organics pvt ltd Research officer1997 - 1997
-
Ranbaxy Laboratories Ltd Scientist1993 - 1997
-
Ranbaxy Laboratories Ltd Reseach Associate1991 - 1993
Education
-
Jamia Hamdard PhD1998 - 2002
-
Jamia Hamdard MPharm1989 - 1991
-
University of Delhi BPharm1985 - 1989
Projects & Funding
Projects & funding information is unavailable.
Publications (563)
- Cannabidiol from Conventional to Advanced Nanomedicines for the Management of Cancer-Associated Pain Save
- Development and Optimization of Piracetam and Shatavarin IV-Loaded Nanoemulsion for Alzheimer's Disease Therapy: In Silico and Experimental Analysis Save
- Early preclinical development of Mycobacterium tuberculosis amino acid biosynthesis pathway inhibitor DRILS-1398 as a potential anti-TB drug Save
- Exploring the neuroprotective role of Asparagus racemosus (Shatavari) in Alzheimer's disease: mechanisms, evidence, and future directions Save
- Management of Alzheimer's Disease With Nanotechnological Interventions and Novel Therapeutics Save
- Nanotechnology in Parkinson's Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes Save
- Recent Advances in Nanocarrier-mediated Combination Drug Therapy for Tackling Solid-resistant Tumors Save
- The Dual Role of Dietary Phytochemicals in Oxidative Stress: Implications for Oncogenesis, Cancer Chemoprevention, and ncRNA Regulation Save
- Advancements in ischemic stroke management: Transition from traditional to nanotechnological approaches Save
- Biomembrane camouflaged nanoparticles: A paradigm shifts in targeted drug delivery system Save